I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
5-Fluoro-3-hydroxy-2-methylbenzoic acid 1 was synthesized from 5-fluoro-2-methylbenzoic acid by nitration, reduction, diazotization and hydrolysis. Another methylcarbamoyl-substituted benzylamine 12 was synthesized from 5-fluoro-2-methylbenzoic acid via the sequential bromination,azido replacement and the reduction.
Eiji Takashiro,; Ichiro Hayakawa,; Tamayo Nitta,; Atsushi Kasuya,; Shuichi Miyamoto,; Yuji Ozawa,; Ryuichi Yagi,; Ikue Yamamoto,; Takahiro Shibayama,; Akihiko Nakagawa,; Yuichiro Yabe. Structure-activity relationship of HIV-1 protease inhibitors containing α-hydroxy-β-amino acids. Detailed study of P1 site. Bioorganic & Medicinal Chemistry. 1999, 7(9),2063-2072.
Xing Fana,; Feng-Hua Zhanga,; Rasha I. Al-Safi,; Li-Fan Zenga,; Yumna Shabaik,; Bikash Debnath,; Tino W. Sanchez,; Srinivas Odde,; Nouri Neamati,; Ya-Qiu Long. Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: A scaffold hopping approach using salicylate and catechol groups. Bioorganic & Medicinal Chemistry. 2011, 19(16), 4935-4952.
Gefahrenhinweise (EU): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Wear protective gloves. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.